2. Search Result
Search Result
Results for "

Entacapone-d<sub>10</sub>

" in MedChemExpress (MCE) Product Catalog:

3328

Inhibitors & Agonists

10

Biochemical Assay Reagents

5

Peptides

1

Inhibitory Antibodies

9

Natural
Products

11

Recombinant Proteins

3255

Isotope-Labeled Compounds

3

Antibodies

16

Click Chemistry

1

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-14280S
    Entacapone-d10

    		COMT Neurological Disease
    Entacapone-d10 is the deuterium labeled Entacapone. Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 µM). Entacapone can be used for the research of Parkinson's disease[1]. Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders[2].
    Entacapone-d10
  • HY-103509
    NNC 05-2090 hydrochloride

    		GABA Receptor Neurological Disease
    NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50< /sub>: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases .
    NNC 05-2090 hydrochloride
  • HY-16562S
    Irinotecan-d10

    (+)-Irinotecan-d<sub>10sub>; CPT-11-d<sub>10sub>; VAL-413-d<sub>10sub>

    		 Topoisomerase Autophagy Cancer
    Irinotecan-d10 is a deuterium labeled Irinotecan ((+)-Irinotecan). Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex[1].
    Irinotecan-d10
  • HY-B0246S
    Carbamazepine-d10

    CBZ-d<sub>10sub>; NSC 169864-d<sub>10sub>

    		 Sodium Channel Autophagy Mitophagy Neurological Disease Cancer
    Carbamazepine-d10 is the deuterium labeled Carbamazepine. Carbamazepine (CBZ), a sodium channel blocker, is an anticonvulsant agent[1][2].
    Carbamazepine-d10
  • HY-N7434S1
    N-Nitrosodiethylamine-d10

    Diethylnitrosamine-d<sub>10sub>; DEN-d<sub>10sub>

    		 DNA/RNA Synthesis Cancer
    N-Nitrosodiethylamine-d10 is the deuterium labeled N-Nitrosodiethylamine[1]. N-Nitrosodiethylamine (Diethylnitrosamine) is a potent hepatocarcinogenic dialkylnitrosoamine. N-Nitrosodiethylamine is mainly present in tobacco smoke, water, cheddar cheese, cured, fried meals and many alcoholic beverages. N-Nitrosodiethylamine is responsible for the changes in the nuclear enzymes associated with DNA repair/replication. N-Nitrosodiethylamine results in various tumors in all animal species. The main target organs are the nasal cavity, trachea, lung, esophagus and liver.
    N-Nitrosodiethylamine-d10
  • HY-139089S
    (Z)-Entacapone-d10

    		Isotope-Labeled Compounds Others
    (Z)-Entacapone-d10 is the deuterium labeled (Z)-Entacapone[1].
    (Z)-Entacapone-d10
  • HY-120146
    NNC 05-2090

    		GABA Receptor Neurological Disease
    NNC 05-2090 is aGABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50 sub>: 10.6 μM). NNC 05-2090 also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases .
    NNC 05-2090
  • HY-139089
    (Z)-Entacapone

    		COMT Metabolic Disease
    (Z)-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor Entacapone (HY-14280). It is also a potential impurity found in commercial preparations of Entacapone and a degradant of Entacapone formed by UV light exposure.
    (Z)-Entacapone
  • HY-Y0504S1
    Trimethylammonium chloride-d10

    Hegzadesil-d<sub>10sub>; Trimethylamine hydrochloric acid-d<sub>10sub>; Trimethylamine monohydrochloride-d<sub>10sub>

    		 Endogenous Metabolite Metabolic Disease
    Trimethylammonium chloride-d10 is the deuterium labeled Trimethylammonium chloride[1]. Trimethylammonium chloride is an endogenous metabolite.
    Trimethylammonium chloride-d10
  • HY-W654320
    Piperin-d10

    Bioperine-d<sub>10sub>; 1-Piperoylpiperidine-d<sub>10sub>

    		 Isotope-Labeled Compounds Endogenous Metabolite P-glycoprotein Autophagy Cancer
    Piperin-d10 is deuterium labeled Piperine. Piperine is an alkaloid, can be isolated from pepper. Piperine can inhibit the activity of P-glycoprotein and CYP3A4. Piperine inhibits HeLa cells with an IC50 of 61.94±0.054 μg/mL .
    Piperin-d10
  • HY-13738S4
    Raloxifene-d10-1

    Keoxifene-d<sub>10sub>; LY156758(free base)-d<sub>10sub>; LY139481-d<sub>10sub>

    		 Estrogen Receptor/ERR Cancer
    Raloxifene-d10-1 is the deuterium labeled Raloxifene[1]. Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM). Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research[2].
    Raloxifene-d10-1
  • HY-14280R
    Entacapone (Standard)

    		COMT Neurological Disease Cancer
    Entacapone (Standard) is the analytical standard of Entacapone. This product is intended for research and analytical applications. Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 µM). Entacapone can be used for the research of Parkinson's disease . Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
    Entacapone (Standard)
  • HY-Y0727S1
    1,5-Dibromopentane-d10

    1,5-Pentanedibromide-d<sub>10sub>; Pentamethylene bromide-d<sub>10sub>; Pentamethylene dibromide-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    1,5-Dibromopentane-d10 is the deuterium labeled 1,5-Dibromopentane[1].
    1,5-Dibromopentane-d10
  • HY-B1674S
    (±)-Leucine-d10

    DL-Leucine-d<sub>10sub>; (RS)-Leucine-d<sub>10sub>

    		 Endogenous Metabolite Bacterial Metabolic Disease
    (±)-Leucine-d10 is the deuterium labeled (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of Leucine, chemosterilant and dietary additive. (±)-Leucine inhibits growth of Escherichia coli HfrH by 92.08%[1].
    (±)-Leucine-d10
  • HY-13272S2
    Dacomitinib-d10 dihydrochloride

    PF-00299804-d<sub>10sub> dihydrochloride; PF-299804-d<sub>10sub> dihydrochloride

    		 Isotope-Labeled Compounds EGFR Apoptosis Cancer
    Dacomitinib-d10 (dihydrochloride) is the deuterium labeled Dacomitinib dihydrochloride. Dacomitinib (PF-00299804) dihydrochloride is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1].
    Dacomitinib-d10 dihydrochloride
  • HY-13272S3
    Dacomitinib-d10

    PF-00299804-d<sub>10sub>; PF-299804-d<sub>10sub>

    		 Isotope-Labeled Compounds EGFR Apoptosis Cancer
    Dacomitinib-d10 is deuterium labeled Dacomitinib. Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1].
    Dacomitinib-d10
  • HY-B0801AS
    Fexofenadine-d10 hydrochloride

    MDL-16455-d<sub>10sub> hydrochloride; Terfenadine carboxylate-d<sub>10sub> hydrochloride

    		 Isotope-Labeled Compounds Histamine Receptor Inflammation/Immunology Endocrinology
    Fexofenadine-d10 (hydrochloride) is deuterium labeled Fexofenadine (hydrochloride). Fexofenadine hydrochloride (MDL-16455 hydrochloride), a H1R antagonist, is an anti-allergic agent used in seasonal allergic rhinitis and chronic idiopathic urticarial (person aged ≥16 years)[1].
    Fexofenadine-d10 hydrochloride
  • HY-13209S
    Ambrisentan-d10

    BSF 208075-d<sub>10sub>; LU 208075-d<sub>10sub>

    		 Isotope-Labeled Compounds Cardiovascular Disease
    Ambrisentan-d10 (BSF 208075-d10; LU 208075-d10) is the deuterium labled Ambrisentan (HY-13209). Ambrisentan is a selective ET type A receptor (ETAR) antagonist.
    Ambrisentan-d10
  • HY-125350
    Entacapone acid

    Tyrphostin AG1290

    		 c-Met/HGFR Metabolic Disease
    Entacapone acid (Tyrphostin AG1290) is a tyrosine kinase inhibitor. Entacapone acid reduces hepatic protein synthesis rate (HPS) in vivo .
    Entacapone acid
  • HY-Y1044S
    1,5-Dihydroxypentane-d10

    1,5-Pentamethylene glycol-d<sub>10sub>; Pentamethylene glycol-d<sub>10sub>; Pentylene glycol-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    1,5-Dihydroxypentane-d10 is the deuterium labeled 1,5-Dihydroxypentane[1].
    1,5-Dihydroxypentane-d10
  • HY-RS13999
    SUB1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    SUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for SUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SUB1 Human Pre-designed siRNA Set A
    SUB1 Human Pre-designed siRNA Set A
  • HY-146227
    DNA topoisomerase II inhibitor 1

    		Topoisomerase Apoptosis Cancer
    DNA topoisomerase II inhibitor 1 (compound 8ed) is a potent DNA topoisomerase II inhibitor. DNA topoisomerase II inhibitor 1 shows anti-proliferative activity. DNA topoisomerase II inhibitor 1 induces apoptosis and cell cycle arrest at sub G1 phase .
    DNA topoisomerase II inhibitor 1
  • HY-B0236S1
    6-Aminocaproic acid-d10

    EACA-d<sub>10sub>; Epsilon-Amino-n-caproic Acid-d<sub>10sub>; 6-Aminohexanoic acid-d<sub>10sub>

    		 Isotope-Labeled Compounds Metabolic Disease
    6-Aminocaproic acid-d10 is the deuterium labeled 6-Aminocaproic acid. 6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders[1][2].
    6-Aminocaproic acid-d10
  • HY-B0978S
    Diethyltoluamide-d10

    DEET-d<sub>10sub>; N,N-Diethyl-m-toluamide-d<sub>10sub>

    		 Parasite Infection
    Diethyltoluamide-d10 is the deuterium labeled Diethyltoluamide[1]. Diethyltoluamide is the most common active ingredient in insect repellents. It is intended to provide protection against mosquitoes, ticks, fleas, chiggers, leeches, and many other biting insects[2].
    Diethyltoluamide-d10
  • HY-14280
    Entacapone
    5 Publications Verification

    		 COMT Neurological Disease Cancer
    Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 µM). Entacapone can be used for the research of Parkinson's disease . Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
    Entacapone
  • HY-14280A
    Entacapone sodium salt

    		COMT Neurological Disease Cancer
    Entacapone sodium salt is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone sodium salt inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone sodium salt is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 μM). Entacapone sodium salt can be used for the research of Parkinson's disease . Entacapone sodium salt serves as as a inhibit of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
    Entacapone sodium salt
  • HY-14794AS
    Levomilnacipran-d10 hydrochloride

    (1S,2R)-Milnacipran-d<sub>10sub> hydrochloride; F2695-d<sub>10sub> hydrochloride

    		 Isotope-Labeled Compounds Serotonin Transporter Metabolic Disease
    Levomilnacipran-d10 ((1S,2R)-Milnacipran-d10) hydrochloride is deuterium labeled Levomilnacipran. Levomilnacipran (F2696; (1R,2S)-milnacipran), an enantiomer of milnacipran, is a selective serotonin and norepinephrine (5-HT/NE) reuptake inhibitor. Levomilnacipran also is a human alpha-adrenergic receptor antagonist, with an IC50 of 3.4 μM. (patent WO2013014263A1) .
    Levomilnacipran-d10 hydrochloride
  • HY-B0535S1
    Ethambutol-d10

    Emb-d<sub>10sub>

    		 Bacterial Antibiotic Infection
    Ethambutol-d10 is the deuterium labeled Ethambutol. Ethambutol is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.
    Ethambutol-d10
  • HY-Y1067S
    Dibenzylamine-d10

    Bisbenzylamine-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    Dibenzylamine-d10 (Bisbenzylamine-d10) is the deuterium labeled Dibenzylamine[1].
    Dibenzylamine-d10
  • HY-B1322AS1
    Amodiaquine-d10 hydrochloride

    Amodiaquin-d<sub>10sub>

    		 Nuclear Hormone Receptor 4A/NR4A Parasite Histone Methyltransferase Isotope-Labeled Compounds Infection Neurological Disease Inflammation/Immunology
    Amodiaquine-d10 hydrochloride is deuterated labeled Amodiaquine (HY-B1322A). Amodiaquine (Amodiaquin), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor. Amodiaquine is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 μM. Anti-inflammatory effect .
    Amodiaquine-d10 hydrochloride
  • HY-12199S
    Pitolisant-d10

    Tiprolisant-d<sub>10sub>

    		 Isotope-Labeled Compounds Histamine Receptor Neurological Disease Endocrinology
    Pitolisant-d10 (Tiprolisant-d10) is deuterium labeled Pitolisant. Pitolisant is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM) .
    Pitolisant-d10
  • HY-N1150S11
    Thymidine-13C10

    DThyd-13C<sub>10sub>; NSC 21548-13C<sub>10sub>

    		 Isotope-Labeled Compounds DNA/RNA Synthesis Endogenous Metabolite Orthopoxvirus Cancer
    Thymidine- 13C10 (DThyd- 13C10; NSC 21548- 13C10) is 13C-labeled Thymidine (HY-N1150). Thymidine, a specific precursor of deoxyribonucleic acid, is used as a cell synchronizing agent. Thymidine is a DNA synthesis inhibitor that can arrest cell at G1/S boundary, prior to DNA replication.
    Thymidine-13C10
  • HY-N0097S4
    Guanosine-13C10

    DL-Guanosine-13C<sub>10sub>; Vernine-13C<sub>10sub>

    		 Isotope-Labeled Compounds Endogenous Metabolite HSV Infection
    Guanosine- 13C10 is the 13C labeled Guanosine (HY-N0097). Guanosine is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity .
    Guanosine-13C10
  • HY-10255AS
    Sunitinib-d10

    SU 11248-d<sub>10sub>

    		 VEGFR PDGFR IRE1 Mitophagy Autophagy Apoptosis Cancer
    Sunitinib-d10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2].
    Sunitinib-d10
  • HY-14136S
    Rimonabant-d10

    SR141716-d<sub>10sub>

    		 Isotope-Labeled Compounds Cannabinoid Receptor Bacterial Infection Metabolic Disease Cancer
    Rimonabant-d10 is deuterium labeled Rimonabant. Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with a Ki of 1.8 nM. Rimonabant (SR141716) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).
    Rimonabant-d10
  • HY-126363S
    Ditiocarb-d10

    Diethyldithiocarbamic acid-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    Ditiocarb-d10 is the deuterium labeled Ditiocarb[1].
    Ditiocarb-d10
  • HY-15917S
    DL-dithiothreitol-d10

    DTT-d<sub>10sub>

    		 Isotope-Labeled Compounds Disulfidptosis Cancer
    DL-dithiothreitol-d10 is the deuterated form of DL-dithiothreitol. DL-dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. When DL-dithiothreitol is oxidized, it forms a stable six-membered ring with an internal disulfide bond .
    DL-dithiothreitol-d10
  • HY-W008151S
    Diphenyl Phosphate-d10

    DPhP-d<sub>10sub>

    		 Isotope-Labeled Compounds Metabolic Disease
    Diphenyl Phosphate-d10 (DPhP-d10) is the deuterium labled Diphenyl Phosphate (HY-W008151). Diphenyl Phosphate inhibits growth and energy metabolism of zebrafish in a sex-specific manner.
    Diphenyl Phosphate-d10
  • HY-15453S
    Devimistat-d10

    CPI-613-d<sub>10sub>

    		 Isotope-Labeled Compounds Cancer
    Devimistat-d10 (CPI-613-d10) is the deuterium-labeled Devimistat (HY-15453) .
    Devimistat-d10
  • HY-19822S2
    Elacestrant-d10

    RAD1901-d<sub>10sub>

    		 Estrogen Receptor/ERR Isotope-Labeled Compounds Cancer
    Elacestrant-d10 is the deuterium labeled of Elacestrant (HY-19822). Elacestrant is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also inhibits growth of ER + breast cancer cell lines in vitro and in vivo .
    Elacestrant-d10
  • HY-B0267CS
    (R)-Oxybutynin-d10

    Aroxybutynin-d<sub>10sub>

    		 Isotope-Labeled Compounds mAChR Neurological Disease
    (R)-Oxybutynin-d10 (Aroxybutynin-d10) is deuterium labeled (R)-Oxybutynin. (R)-Oxybutynin (Aroxybutynin) is the racemic isomer of Oxybutynin and an orally active muscarinic receptor antagonist. (R)-Oxybutynin has antispasmodic, antimuscarinic, and anticholinergic activities and competitively antagonizes carbachol-induced contractions. (R)-Oxybutynin can be used to study urinary incontinence caused by neurogenic bladder dysfunction .
    (R)-Oxybutynin-d10
  • HY-19652S1
    (S)-Oxybutynin-d10

    Esoxybutynin-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    (S)-Oxybutynin-d10 (Esoxybutynin-d10) is deuterium labeled (S)-Oxybutynin (Esoxybutyni) .
    (S)-Oxybutynin-d10
  • HY-17563S2
    2'-Deoxyguanosine-13C10

    Deoxyguanosine-13C<sub>10sub>; Guanine deoxyriboside-13C<sub>10sub>

    		 Isotope-Labeled Compounds Endogenous Metabolite Cancer
    2'-Deoxyguanosine- 13C10 (Deoxyguanosine- 13C10; Guanine deoxyriboside- 13C10) is 13C-labeled 2'-Deoxyguanosine (HY-17563). 2'-Deoxyguanosine (Deoxyguanosine) is deoxyguanosine.
    2'-Deoxyguanosine-13C10
  • HY-B0228S13
    Adenosine-13C10

    Adenine riboside-13C<sub>10sub>; D-Adenosine-13C<sub>10sub>

    		 Isotope-Labeled Compounds Nucleoside Antimetabolite/Analog Endogenous Metabolite Autophagy Apoptosis Metabolic Disease Cancer
    Adenosine- 13C10 (Adenine riboside- 13C10; D-Adenosine- 13C10) is 13C-labeled Adenosine (HY-B0228). Adenosine (Adenine riboside), a ubiquitous endogenous autacoid, acts through the enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Adenosine affects almost all aspects of cellular physiology, including neuronal activity, vascular function, platelet aggregation, and blood cell regulation.
    Adenosine-13C10
  • HY-Y0378S
    D-Leucine-d10

    (R)-Leucine-d<sub>10sub>

    		 Isotope-Labeled Compounds Endogenous Metabolite Neurological Disease
    D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1].
    D-Leucine-d10
  • HY-10933S
    CX516-d10

    BDP 12-d<sub>10sub>

    		 Isotope-Labeled Compounds iGluR Neurological Disease
    CX516-d10 is the deuterium labeled CX516. CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI)[1].
    CX516-d10
  • HY-B0448S
    Phenytoin-d10

    5,5-Diphenylhydantoin-d<sub>10sub>

    		 Sodium Channel Virus Protease Neurological Disease
    Phenytoin-d10 is the deuterium labeled Phenytoin. Phenytoin (5,5-Diphenylhydantoin) is a potent Voltage-gated Na+ channels (VGSCs) blocker. Phenytoin has antiepileptic activity and reduces breast tumour growth and metastasis in mice[1][2].
    Phenytoin-d10
  • HY-128793S2
    trans-Stilbene-d10

    (E)-Stilbene-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    trans-Stilbene-d10 is the deuterium labeled trans-Stilbene[1]. trans-Stilbene ((E)-Stilbene) is used in the manufacturing of dye lasers, optical brighteners, non-steroidal synthetic estrogens[2].
    trans-Stilbene-d10
  • HY-18986S
    SAR405838-d10

    MI-77301-d<sub>10sub>

    		 Isotope-Labeled Compounds Cancer
    SAR405838-d10 (MI-77301-d10) is the deuterium labeled SAR405838 (HY-18986). SAR405838 (MI-77301), an analog of MI-773, is a highly potent and selective MDM2-p53 interaction inhibitor. SAR405838 binds to MDM2 with a Ki of 0.88 nM. SAR405838 induces apoptosis and has potent antitumor activity .
    SAR405838-d10
  • HY-W775325S
    7-Hydroxycannabidiol-d10

    7-OH-CBD-d<sub>10sub>

    		 Isotope-Labeled Compounds Others
    7-Hydroxycannabidiol-d10 is deuterium-labeled 7-Hydroxycannabidiol 100 μg/mL in Acetonitrile (HY-W775325) .
    7-Hydroxycannabidiol-d10

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: